TRUSTEES OF TUFTS COLLEGE
Patent Owner
Stats
- 216 US PATENTS IN FORCE
- 22 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 216 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 20,063 Total Citation Count
- Jun 08, 1978 Earliest Filing
- 238 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0036,434 PHOTOLUMINESCENT NANOPARTICLES AND THEIR USES IN DETECTION OR QUANTIFICATION OF SINGLET OXYGENAug 01, 17Feb 08, 18[A61K, G01N]
2017/0370,709 Imaging System To Characterize Dynamic Changes In Cell And Particle CharacteristicsJun 08, 16Dec 28, 17[G01N, G02B, G01B]
2017/0333,461 PEPTIDOMIMETIC INHIBITORS OF POST-PROLINE CLEAVING ENZYMESJun 19, 17Nov 23, 17[A61K, C07F, C07D]
2017/0320,040 METHODS AND KITS FOR REMOVING ORGANIC POLLUTANTS FROM A CONTAMINATED SAMPLEMay 05, 17Nov 09, 17[B08B, B09C, B01J, C02F]
2017/0184,578 METHODS FOR DETECTING TARGET ANALYTES AND ENZYMATIC REACTIONSMar 13, 17Jun 29, 17[G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9839646 Small molecule enhancer for dendritic cell cancer vaccinesNov 23, 15Dec 12, 17[A61K, C07F, A61N]
9834616 Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding proteinMar 23, 15Dec 05, 17[A61K, C07K]
9809838 Methods for determining the concentration of an analyte in solutionOct 11, 16Nov 07, 17[C12Q, G01N]
9757400 Peptidomimetic inhibitors of post-proline cleaving enzymesFeb 12, 16Sep 12, 17[A61K, C07F, C07D]
9731052 Methods for stepwise deposition of silk fibroin coatingsMay 06, 15Aug 15, 17[A61K, C09D, A61L]
9691873 Transient devices designed to undergo programmable transformationsSep 21, 12Jun 27, 17[H01L, B82Y, H01Q, G11B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0258,889 COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTSAbandonedApr 20, 17Sep 14, 17[A61K, B82Y]
2017/0246,255 Stable Analogs of Peptide and Polypeptide TherapeuticsAbandonedJul 24, 15Aug 31, 17[A61K]
2017/0173,161 COMPOSITIONS AND METHODS FOR OCULAR DELIVERY OF A THERAPEUTIC AGENTAbandonedSep 28, 16Jun 22, 17[A61K, A61F]
2016/0250,237 SOFT PROTEASE INHIBITORS AND PRO-SOFT FORMS THEREOFAbandonedNov 04, 15Sep 01, 16[A61K]
2016/0032,397 MAST CELL CANCER-ASSOCIATED GERM-LINE RISK MARKERS AND USES THEREOFAbandonedMar 13, 14Feb 04, 16[C12Q]
2016/0000,857 Method of Regulating Glucose Metabolism, and Reagents Related TheretoAbandonedMay 13, 15Jan 07, 16[A61K]
2015/0299,795 CANCER-ASSOCIATED GERM-LINE AND SOMATIC MARKERS AND USES THEREOFAbandonedMay 30, 13Oct 22, 15[C12Q]
2015/0267,187 Designer Ubiquitin Ligases for Regulation of Intracellular Pathogenic ProteinsAbandonedDec 27, 12Sep 24, 15[C12N, C07K]
2015/0202,218 Broad Spectrum Inhibitors of the Post Proline Cleaving Enzymes for Treatment of Hepatitis C Virus InfectionsAbandonedAug 01, 13Jul 23, 15[A61K]
2015/0056,294 METHODS AND COMPOSITIONS FOR PREPARING A SILK MICROSPHEREAbandonedApr 12, 13Feb 26, 15[A61K, C07K]
2014/0379,094 FIBROUS PROTEIN FUSIONS AND USE THEREOF IN THE FORMATION OF ADVANCED ORGANIC/INORGANIC COMPOSITE MATERIALSAbandonedMay 16, 14Dec 25, 14[A61L]
2014/0371,155 NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOFAbandonedJan 24, 14Dec 18, 14[C12N, C07K]
2014/0287,043 COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTSAbandonedApr 23, 12Sep 25, 14[A61K]
2014/0105,978 SILK MICROSPHERES FOR ENCAPSULATION AND CONTROLLED RELEASEAbandonedOct 17, 13Apr 17, 14[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.